ArticleNature aging2024

Cerebrospinal fluid proteomics in patients with Alzheimer's disease reveals five molecular subtypes with distinct genetic risk profiles.

Betty M Tijms et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.